Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation

Abstract

Systemic delivery of tripterine (TPR) is challenged by its insoluble property and unsuitable pharmacokinetics. This work aimed to develop polymeric nanoparticles (NPs) combined with the reticuloendothelial system (RES) saturation to improve the in vivo distribution and antitumor activity of TPR. TPR-loaded nanoparticles (TPR-NPs) were prepared by the low-energy emulsification/evaporation method and characterized with particle size, entrapment efficiency, and morphology. The resulting TPR-NPs were 75 nm around in particle size and displayed a sustained drug release in pH 7.4 medium. Pharmacokinetic studies revealed that TPR-NPs had the advantage in bettering the pharmacokinetic properties of TPR over the solution formulation. However, the ameliorative effect on pharmacokinetics was more significant in the case of RES saturation (i.e. preinjection of blank NPs). Preinjection of blank NPs followed by injection of TPR-NPs resulted in higher distribution of TPR into the tumor due to reduced sequestration of TPR-NPs by RES. In tumor-bearing mice (prostatic cancer model), TPR-NPs treatment with RES saturation exhibited a superior antitumor efficacy to free TPR and TPR-NPs alone. It can be concluded that formulating TPR into polymeric NPs in combination with RES saturation is an effective means to address the systemic delivery of TPR. ARTICLE HISTORY

Optimization of Preparation and Preclinical Pharmacokinetics of Celastrol-Encapsulated Silk Fibroin Nanoparticles in the Rat

“…The circulation time of CL in blood was longer with the NP formulation when compared to that with CL in solution. Our findings align with previous reports on the improvement of pharmacokinetic profiles with various CL-NPs [20,24,25,26].…”

Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect

“…The micrographs were taken at an acceleration voltage of 100 kV. EE and DL were determined after separating free drug from MPE-SeNPs through a centrifugal ultrafiltration technique 37 . Unentrapped components were firstly removed from the system by centrifugation at 5000 rpm (Centrifuge 5424R, Eppendorf, NY, USA), and then the purified MPE-SeNPs were subjected to centrifugal ultrafiltration using an MWCO 50 K filter device (Amicon ® , Millipore, USA).…”

Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach

“…Results demonstrate that the administration of empty nanocarriers quickly saturated the RES components, and increased the pharmacokinetic profile of nanotherapeutics that were following injection. [ 142 ] Unfortunately, this approach could make patients sensitive to opportunistic pathogen infection that occurred during the treatment.…”